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Abstract
Background: Tools for authenticating cell lines are critical for quality control in cell-based biological experiments.
Currently there are methods to authenticate human cell lines using short tandem repeat (STR) markers based on
the technology and procedures successfully used in the forensic community for human identification, but there are
no STR based methods for authenticating nonhuman cell lines to date. There is significant homology between the
human and vervet monkey genome and we utilized these similarities to design the first multiplex assay based on
human STR markers for vervet cell line identification.
Results: The following STR markers were incorporated into the vervet multiplex PCR assay: D17S1304, D5S1467,
D19S245, D1S518, D8S1106, D4S2408, D6S1017, and DYS389. The eight markers were successful in uniquely
identifying sixty-two vervet monkey DNA samples and confirmed that Vero76 cells and COS-7 cells were derived
from Vero and CV-1 cells, respectively. The multiplex assay shows specificity for vervet DNA within the determined
allele range for vervet monkeys; however, the primers will also amplify human DNA for each marker resulting in
amplicons outside the vervet allele range in several of the loci. The STR markers showed genetic stability in over
sixty-nine passages of Vero cells, suggesting low mutation rates in the targeted STR sequences in the Vero cell line.
Conclusions: A functional vervet multiplex assay consisting of eight human STR markers with heterozygosity
values ranging from 0.53-0.79 was successful in uniquely identifying sixty-two vervet monkey samples. The
probability of a random match using these eight markers between any two vervet samples is approximately 1 in
1.9 million. While authenticating a vervet cell line, the multiplex assay may also be a useful indicator for human cell
line contamination since the assay is based on human STR markers.
Background
Misidentification of cell lines has been a continuing pro-
blem in academia and industry for decades [1-6]. The
most common causes of cell misidentification include
mislabeling, contamination of cell lines (i.e. feeder cells
used in cocultivation of human stem cells), and xeno-
grafting (transplanting living cells, tissues, or organs
from one species to another) [7,8]. Erroneous data have
been published based on results derived from misidenti-
fied cells [9] and only recently has an active push for
cell authentication been proposed. Nardone et al.
attempted to raise awareness of this issue in an open
letter to Secretary Michael O. Leavitt at the U.S.
Department of Health and Human Services [10-12].
Subsequently, NIH has urged researchers to authenticate
cell lines in the “Notice Regarding Authentication of
Cultured Cell Lines”, an addition to their Guidelines for
Research [13]. As a result, more scientific journals are
now requiring proof of cell line authentication for sub-
mission of manuscripts [14]. Major cell repositories are
confirming cell line identity by incorporating these data
into a large comprehensive international reference data-
base [15]. There are also extensive lists of documented
misidentified cells available to educate cell culture users
[3,16]. In 2009, a working group was formed to develop
a standard for authentication of human cells along with
a database of short tandem repeat (STR) profiles for
human cell lines [14].
Recently, the use of short tandem repeat markers has
been recommended for cell line authentication and
these methods are currently being used to identify
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kers used in human identification have tetranucleotide
repeats for reduced stutter product formation and offer
a narrow allele size range that is beneficial for multi-
plexing [19]. Di- and trinucleotide repeats tend to have
higher stutter due to strand slippage during PCR and
these markers are generally avoided [20]. Many com-
mercially available kits for human STR profiling target
these tetranucleotide repeat regions, give rapid results,
and have been well characterized in the forensic com-
munity http://www.cstl.nist.gov/biotech/strbase[21].
Additional human STR markers have also been devel-
oped for use in complex multiplex assays to aid in
human identification and could also be useful in human
cell line authentication [22].
Cell authentication targeting STR loci can also be
expanded to nonhuman cell lines based on genome
availability. This study describes a method to identify
cell lines derived from the vervet monkey (C. aethiops
sabaeus), commonly known as the African green mon-
key. Vero cells isolated from the kidney of an African
g r e e nm o n k e yi n1 9 6 2a r ec o m m o n l yu s e df o rv i r u s
amplification, vaccine development, and cytotoxicity
assays [23-29]. It has been shown that humans and ver-
vets share homology in their STR regions enabling the
use of human STR markers for vervet identification
[30,31]. The genome for the vervet monkey has not
been fully sequenced; however the completed vervet
reference sequence is available through The Vervet
Functional Genome Project (VFGP). The VFGP is a col-
laborative effort between researchers at UCLA and
McGill University and the Genome Québec Innovation
Centre. Data has been published from the collaborative
group describing concordance between vervet and
known human STR markers [31]. Utilizing known
human STR markers and concordant regions found in
the vervet reference sequence, we have developed a mul-
tiplex assay containing eight human STR markers that
successfully genotyped sixty-two vervet genomic DNA
samples from monkeys and commonly used vervet cell
lines.
Methods
Selection of loci
STR markers with high heterozygosity values are benefi-
cial in a multiplex assay as they increase the variability
and reduce the chance of a random sample match [19].
This was an important parameter because fifty-nine
human STR markers were screened against a panel of
vervet monkey DNA samples. Eight STR markers were
selected based on the following criteria: 1) heterozygos-
ity values greater than 50%, 2) locus must have at least
4 unique alleles, 3) locus must be present in every sam-
ple tested, 4) locus must contain a tetranucleotide
repeat, and 5) primers for each marker must amplify
products in a functional multiplex. Eight human loci
(D8S1106, D1S518, D6S1017, D17S1304, D4S2408,
D5S1467, D19S245, and DYS389) met the criteria listed
above and were incorporated into the vervet multiplex.
D17S1304, D5S1467, and D19S245 were identified in
the vervet genetic linkage map published by Jasinska et
al. [31]. D1S518, D8S1106, and DYS389 were described
by Newman et al. in a study utilizing human STR mar-
kers for vervet parentage determination [30]. D4S2408
and D6S1017 loci are included in a 26plex assay used
for identification of human DNA samples [32]. Chromo-
somal locations for these markers were found by search-
ing the National Center for Biotechnology Information
(NCBI) UniSTS browser [33] for human STR markers.
These human chromosomal locations were used to find
regions of sequence similarity within the vervet refer-
ence sequence supplied by The Vervet Functional Gen-
ome Project using the UCSC Genome Browser [34].
Primer design
Primer3 software http://fokker.wi.mit.edu/primer3/input.
htm[35] was used to design PCR primers by inputing
the downloaded concordant vervet sequences from the
UCSC Genome Browser. The parameters for Primer3
were set to target primers with melting temperatures of
60°C. AutoDimer software was used to assess primer-
dimer interactions and hairpin structures within the pri-
mers chosen for the vervet multiplex [36]. Forward pri-
mers were labeled with one of the following fluorescent
dyes at the 5’ end: 6FAM™ (blue), VIC™ (green),
NED™ (yellow), or PET™ (red) (Applied Biosystems,
Foster, CA). In some cases, an additional guanine base
(G) or a “PIGtail” sequence (GTTTCTT) was added to
the 5’ end of the unlabeled reverse primers to promote
complete adenylation (Eurofins MWG Operon, Hunts-
ville, AL) [37] (Table 1).
DNA and cell lines
Sixty vervet monkey genomic DNA samples were
obtained from The Nonhuman Primate Research Center
Consortium Genome Banks at the University of
Washington. These samples originated from the Vervet
Research Colony which is part of the Wake Forest Uni-
versity Primate Center and consists of descendants from
fifty-seven original founders that were imported from
Saint Kitts and Nevis in the mid-1970’s. It has been a
closed colony since the mid-1980’s. Genomic DNA from
hamster, rat, gerbil, mouse, pig, baboon, rhesus, and
cynomolgus monkey were obtained from Zyagen (San
Diego, CA). A total of ten human genomic DNA sam-
ples from NIST SRM 2391b (components 1, 3, 4, 5, 7, 8,
9, 10), AmpFℓSTR
® Control DNA 007 (Applied Biosys-
tems), and a highly characterized human DNA sample
Almeida et al. BMC Biotechnology 2011, 11:102
http://www.biomedcentral.com/1472-6750/11/102
Page 2 of 10of male origin from NIST (N4124) were used for human
reference samples. The following cell lines were
obtained from The American Type Culture Collection
(ATCC, Manassas, VA): Vero (CCL-81), Vero76
(CRL1587), COS-7 (CRL-1651), CV-1 (CCL-70), and
HeLa (CCL-2) cells. Vero cells were grown in Minimum
Essential Medium (MEM) Alpha (Invitrogen, Carlsbad,
CA) with 10% fetal bovine serum (FBS) (Invitrogen, US
origin, qualified), COS-7 and Vero76 cells were grown
in Dulbecco’s MEM (ATCC) with 10% FBS, and CV-1
and HeLa cells were grown in Eagle’s MEM (ATCC)
with 10% FBS. All cells were grown in a humidified 5%
CO2 balanced-air atmosphere at 37°C. Vero 76, COS-7
and CV-1 cells were harvested at passage number 2
using 0.25% trypsin/0.53 mM EDTA solution (ATCC).
Vero cells were harvested over a period of 6 months at
passages 7, 14, 22, 35, 43, 58, 63, and 69 to study
changes in the STR profile over high passage number.
Trypsin activity was quenched by the addition of an
equivalent volume of growth medium and one million
cells from each cell line were counted using the Multisi-
zer 3 Coulter Counter (Beckman Coulter, Brea, CA).
The Wizard DNA Extraction kit (Promega, Madison,
WI) was used to isolate DNA from harvested cells.
DNA was quantified using a Nanodrop 1000 (Thermo
Scientific, Wilmington, DE) at an absorbance of 260 nm.
PCR amplification
PCR amplification was performed on a Gene Amp 9700
or Veriti thermal cycler (Applied Biosystems, Foster
City, CA). The reaction mixture of 20 μLc o n t a i n e d6
ng of vervet DNA, 1× GeneAmp PCR Gold buffer
(Applied Biosystems), 2 μMM g C l 2 (Applied Biosys-
tems), 250 μM dNTPs (USB Corporation, Cleveland,
OH), forward labeled and reverse primers (Table 1), 1 U
AmpliTaq Gold DNA Polymerase (Applied Biosystems),
and 0.16 mg/mL BSA (Sigma-Aldrich). PCR conditions
for the multiplex assay are as follows: denaturation for
11 min at 95°C, amplification for 30 cycles of 45 sec at
94°C, 2 min at 59°C, and 1 min at 72°C, extension for
60 min at 60°C, and a final soak at 25°C.
PCR product analysis
Samples were prepared by adding 1 μL of amplified pro-
duct and 0.3 μL of GeneScan™ 500 LIZ internal size
standard (Applied Biosystems) to 8.7 μLo fH i - D i ™
(Applied Biosystems) for separation on the 16-capillary
ABI 3130xl Genetic Analyzer (Applied Biosystems). A
five dye matrix was established under the G5 filter with
d y e s6 F A M ,V I C ,N E D ,P E T ,a n dL I Z .P O P - 4 ™
(Applied Biosystems) was utilized on a 36 cm capillary
array (Applied Biosystems) with 1× ACE buffer
(Amresco, Solon, OH). Samples were injected electroki-
netically for 10 sec at 3 kV. The STR alleles were sepa-
rated at 15 kV at a run temperature of 60°C. Data from
the 3130xl was analyzed using the GeneMapper ID-X
v1.1 Software (Applied Biosystems). Bins and panels
were generated in GeneMapper ID-X based on fragment
length data from the sixty vervet monkey profiles using
fixed bin allele sizes to determine allele calls. Calibration
of repeat number to allele fragment length was deter-
mined by DNA sequencing.
DNA sequencing
DNA samples were sequenced to determine the frag-
ment length and number of correlating tetranucleotide
repeat units. Sequencing primers were initially designed
outside of the multiplex primer region; however, these
primers did not always amplify the targeted region effi-
ciently. This may be due to single-nucleotide poly-
morphisms (SNPs) located in the primer binding
sequence or non-specific binding of the primer to other
regions of the genome. As a result, the majority of pri-
mers used in the multiplex for genotyping were also
used for sequencing due to difficulty in finding effective
sequencing primers. At least two homozygote samples
were sequenced for each STR locus to determine the
corresponding number of repeats for each allele. The
Table 1 Primers used for STR amplification
STR Marker Forward Primer (5’-3’) Reverse Primer (5’-3’) Primer μM
D8S1106 [FAM]-GTTTACCCCTGCATCACTGG GTCAGAATTGCTCATAGTGCAAGA 0.045
DYS389 [FAM]-CCAACTCTCATCTGTATTATCTATG GTCTTATCTCCACCCACCAGA 0.200
D1S518 [VIC]-GCAGATCTTGGGACTTCTCG GTGTGGGCAACTGCATTAGAG 0.420
D6S1017 [VIC]-CTGGCACAGGATAGGTGCTC GATTGAACCAGATGGGAACGA 0.300
D17S1304 [NED]-ACCATGTCCTCTGGTTCTGG GTTTCTTACAGGTGGGACTTGGTGAAA 0.040
D4S2408 [NED]-TCATTTCCATAGGGTAAGTGAAAA GCCATGGGGATAAAATCAGA 0.200
D5S1467 [PET]-GCCTAAGGTGGTGAATTGGA GTGCATTATTGGAGGCTTTCTC 0.060
D19S245 [PET]-GACCTGCAATCAGCCATTTT GTTCTTGCAGTCTGTGGCTTG 0.360
Reverse primers that did not end in a guanine base at the 5’end were modified by adding an additional guanine (G) base or a “PIGtail” sequence (GTTTCTT) to
the 5’ end of the reverse primer (underlined) to promote complete adenylation [37]. Primer concentrations listed are final concentrations of forward and reverse
primers in a 20 μL reaction volume. Primer concentrations were determined empirically based on peak height, DNA concentration, and number of cycles in the
PCR program.
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unlabeled forward and reverse primers (Table 2) using
the PCR reaction specified in the PCR Amplification
section with the following thermal cycling program:
denaturation for 10 min at 95°C, amplification for 35
cycles of 1 min at 94°C, 1 min at 55-60°C (annealing
temperature specific to individual primers), and 1 min
at 72°C, extension for 45 min at 60°C, and a final soak
at 25°C. Samples were treated with 2 μlo fE x o S a p - I T ™
(USB Corporation) per 5 μlo fP C Rp r o d u c tt or e m o v e
unincorporated primers and dNTPs and run on a ther-
mocycler with the following conditions: 90 min at 37°C,
20 min at 80°C to inactivate the enzymes, and a final
soak at 25°C. Samples were then sent to Eurofins MWG
Operon for sequencing using BigDye
® Terminator v3.1
(Applied Biosystems).
Multiplex assay development
Optimization of the multiplex assay involved identifying
an appropriate annealing temperature suitable for all
primers included in the assay. Annealing temperature
gradients ranging from 55°C to 60°C were used to
screen the multiplex primers for optimal product forma-
tion. The concentration of vervet monkey genomic
DNA (ranging from 1 ng to 10 ng) was also optimized
based on the primer concentration and program cycle
number. We found the most effective parameters for
the multiplex to be the following: 59°C annealing tem-
perature, 6 ng of vervet DNA, and 30 cycles for the
amplification program. The primer concentrations were
first optimized individually in monoplex reactions and
then were combined into the final multiplex (Table 1).
Primer concentrations were empirically determined
based on peak height balance within the multiplex.
Mixture analysis
Mixture samples containing genomic DNA extracted
from Vero and CV-1 cells and Vero and HeLa cells
were analyzed to determine the detection of low levels
of contamination in Vero cells using the vervet multi-
plex assay. DNA from Vero and CV-1 cells were added
to individual reactions with a final concentration of 6 ng
of DNA in the following ratios 1:1, 2:1, 3:1, 5:1, 7:1, 9:1,
and 10:1. Reciprocal reactions were also prepared using
DNA from CV-1 and Vero cells. The same procedure
was repeated using DNA from Vero and HeLa cells, fol-
lowed by reciprocal reactions with DNA from HeLa and
Vero cells.
DNA analysis
The heterozygosity (H) values were calculated by divid-
ing the number of heterozygotes at a locus into the total
number of individuals. The probability of identity (PI)
was calculated by the summation of the square of the
genotype frequencies. The probability of a random
match (PM) for a full profile was calculated by multiply-
ing the inverse of each genotype frequency for each
marker. In the formulas below, n is the number of sam-
ples, Pi is the frequency of the i
th allele, xi is the fre-
quency of the i
th genotype [19]. A NIST in-house Excel-
based statistics program developed by David Duewer
was used for these calculations.
Heterozygocity(H) =1−
n 
i
P2
i
Probability of identity(PI) =
n 
i=1
x2
i
Probability of randommatch(PM) =
1
xi

for a single marker

Results and Discussion
STR marker characterization
The vervet multiplex assay was developed by including
eight human STR markers, all comprised of tetranucleo-
tide repeats. The multiplex successfully identified sixty
vervet monkey DNA samples received from the
Washington National Primate Center resulting in
unique profiles for each sample analyzed. Amplified
PCR products for all eight loci were observed in every
sample. Allele distributions were determined by screen-
ing the panel of vervet DNA samples and analyzing frag-
ment lengths. The number of repeats was determined by
Table 2 Sequencing primers used for sequence
verification and repeat number determination
STR
Marker
Sequencing Primers (5’-3’) Amplicon Size
(bp)
Tm
(°C)
D8S1106 F- GTTTACCCCTGCATCACTGG
R- GGTGGCCTAACCAGAGTTGA*
267-291 55
DYS389 F - CCAACTCTCATCTGTATTATCTATG
R - GTCTTATCTCCACCCACCAGA
321-337 60
D1S518 F - GCAGATCTTGGGACTTCTCG
R - GTGTGGGCAACTGCATTAGAG
182-198 55
D6S1017 F - CTGGCACAGGATAGGTGCTC
R - GATTGAACCAGATGGGAACGA
354-374 59
D17S1304 F - ACCATGTCCTCTGGTTCTGG
R-
GTTTCTTACAGGTGGGACTTGGTGAAA
197-213 60
D4S2408 F - TCATTTCCATAGGGTAAGTGAAAA
R - GCCATGGGGATAAAATCAGA
336-360 60
D5S1467 F - GCCTAAGGTGGTGAATTGGA
R - GAAGATGGCCCATTTCCATTT*
313-329 60
D19S245 F - GACCTGCAATCAGCCATTTT
R - GTTCTTGCAGTCTGTGGCTTG
225-249 60
*New primers designed specifically for sequencing purposes. All other primers
are original primers developed for the multiplex assay.
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and correlations were made between the fragment
lengths and the number of repeats (Table 3).
Four vervet cell lines, Vero, Vero76, CV-1 and COS-7,
were also tested using the multiplex assay (Figure 1).
Vero and Vero76 genomic DNA samples resulted in
identical profiles, confirming that these two cell lines
were derived from the same vervet individual [38]. Simi-
larly, DNA extracted from COS-7 cells produced the
same profile as the CV-1 cell line from which it was
derived [39] (Table 4). Genomic DNA from HeLa cells
(female human origin), a common cell culture contami-
nant, was also analyzed with the multiplex assay which
resulted in an “irregular profile”. The HeLa alleles were
outside of the determined allele range for vervet mon-
keys in three of the loci (D4S2408, D5S1467, and
D 1 9 S 2 4 5 )a n dn oa m p l i f i e dp r o d u c tw a sd e t e c t e da tt h e
DYS389 locus. This was expected because DYS389 is a
human marker for the Y chromosome, found only in
males, and HeLa cells are female in origin. In addition
to HeLa cell DNA, ten human DNA samples from NIST
SRM 2391b (eight components), N4124, and Control
DNA 007 were analyzed using the vervet multiplex
assay and amplified products were present for all eight
loci, excluding DYS389 if the sample was of female ori-
gin. In the eleven human samples tested, amplicon sizes
for the D19S245 marker ranged from 182 to 202 base
pairs, 147 to 176 base pairs for the D5S1467 marker,
and 319 to 331 base pairs for the D4S2408 marker (illu-
strated in Figure 2). These allele ranges correlate with
the results found in HeLa DNA.
In vervet monkeys, the DYS389 marker is amplified
whether the individual is male or female. This data agrees
with a previous study indicating the primers used to
amplify the DYS389 marker yield PCR products in both
male and female Japanese macaques, suggesting the locus
is either autosomal in nature or has sequence homology
on the X and Y chromosomes [40]. In humans, the pri-
mers for DYS389 amplify two products in male samples,
DYS389I and DYS389II, and it was found that these
products do not exist in Japanese macaques. The data
from this study suggests that the same is true for vervet
monkeys at this locus. PCR products for the DYS389
marker from Japanese macaques range from 320 to 360
bases, similar to the allele ranges observed in this study
for vervets, and in human males they range from 239 to
263 (DYS389I) and 353 to 385 (DYS389II) bases. The dif-
ferences in the amplified product size for the DYS389
locus can be useful in distinguishing between cell lines of
vervet and human (male) origin.
Sequencing repeat regions
The D4S2408 and D6S1017 loci were based on the
human STR markers from a 26plex assay developed to
aid in human identification [22]. Since the D4S2408 and
the D6S1017 loci are incorporated in both the human
26plex and the vervet multiplex assays, the samples
tested were hypothesized to have the same number of
repeats at these loci when the two assays were com-
pared using the same DNA samples; however, this was
not the case. When genomic DNA from HeLa cells,
Vero cells, and human N4124 was tested with the
human 26plex the resulting repeats for the D6S1017
locus were (8, 8), (8, 9), and (11, 12), respectively. When
the same DNA was amplified with the vervet multiplex
for the D6S1017 locus the resulting repeats were (10,
10), (10, 11), and (13, 14), respectively. The vervet multi-
plex results have two additional repeats when compared
to the 26plex data and this is due to differences found
in the nomenclature of the repeat region motif. In the
26plex, the repeat motif is defined as ATCC and the
flanking sequence ACCA ACCA does not vary within
human DNA sequence at this marker. In vervet DNA,
t h ef l a n k i n gs e q u e n c ed o e sv a r ya n di st h e r e f o r ei n c o r -
porated in the designated repeat motif [ATCC]n[ACCC]
n[ACCA]n. Differences in nomenclature also explain
why the human 26plex assay and the vervet multiplex
assay give different results at the D4S2408 locus when
comparing the same DNA sample. The D4S2408 locus
in the 26plex assay has a simple ATCT repeat in human
Table 3 Correlating STR marker fragment length with repeat number
Human Marker GenBank Repeat Region Allele Distribution (bp) Number of Repeats
D8S1106 G09378 [ATAG]n 109, 121, 125, 129, 133 7, 10, 11, 12, 13
DYS389 G09600 [CTAT] n 321, 325, 329, 337 10, 11, 12, 14
D1S518 G07854 [AGAT] n 182, 186, 190, 194, 198 13, 14, 15, 16, 17
D6S1017 G08578 [ATCC] n [ACCC] n [ACCA] n 354, 358, 362, 366, 370, 374 10, 11, 12, 13, 14, 15
D17S1304 G07960 [TATC] n 197, 201, 205, 209, 213 10, 11, 12, 13, 14
D4S2408 G08341 [ATCT] n [ACCC][ATCT] n [ACCT] n [ATCT] 336, 344, 348, 352, 356, 360 13, 15, 16, 17, 18, 19
D5S1467 G08455 [AGAT] n 173, 181, 185, 189 8, 10, 11, 12
D19S245 L13119 [ATCT] n [ATCA][TCTA] n 225, 229, 233, 237, 241, 245, 249 16, 17, 18, 19, 20, 21, 22
The eight human STR markers incorporated in the multiplex assay with corresponding repeat region, fragment length (based on LIZ GeneScan™500 size
standard), and number of repeats based on the DNA analysis from sixty-two vervet monkey samples. The correlation of the allele size and number of repeats
was determined based on sequencing data.
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Page 5 of 10Figure 1 Genetic profile of the Vero cell line using the vervet multiplex assay and bins and panels developed in GeneMapper ID-X.
The blue, green, black, and red peaks in the electropherogram correspond to the fluorescently labeled forward primers for that STR marker
(FAM, VIC, NED, and PET, respectively). Relative fluorescent units (RFUs) are depicted on the y-axis and fragment length on the x-axis. The
number(s) below each peak represent the number of repeats at that locus. Vero peaks appear in the shaded bins and panels designated for
each STR marker. The bins represent individual alleles for a specific marker.
Table 4 Genetic profiles for Vero, Vero76, COS-7, CV-1 cells and two examples of human profiles using the vervet
multiplex assay
D8S1106 DYS389 D1S518 D6S1017 D17S1304 D4S2408 D5S1467 D19S245
Vero/Vero 76 12, 12 11, 11 15, 16 10, 11 12, 13 15, 16 10, 10 20, 20
CV-1/COS-7 11, 13 11, 11 13, 16 11, 12 11, 11 19, 19 11, 11 21, 21
HeLa 13, 13 NA** (188 bp, 192 bp)* 10, 10 11, 12 (327 bp, 331 bp)* (147 bp)* (193 bp, 197 bp)*
N4124 12, 13 (251 bp, 373 bp)* (192 bp, 196 bp)* 13, 14 12, 12 (322 bp)* (147 bp, 176 bp)* (189 bp, 193 bp)*
*Apparent size based on LIZ GeneScan™500 size standard. These values do not fall within the vervet allele distribution range or in the designated bins
(developed using GeneMapper ID-X Software) for the vervet monkey and therefore are listed as sizes as opposed to repeat numbers.
**No amplified product was detected at this locus because it is of female origin.
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more complex repeat of [ATCT]n[ACCC][ATCT]n
[ACCT]n[ATCT]. The flanking regions outside the
repeat region are identical in both human and vervet
sequence. Due to differences in length of the D4S2408
repeat region found in human and vervet DNA, human
samples result in smaller fragment lengths of the repeat
amplicon when compared to the vervet allele range in
the multiplex assay.
Evaluation of STR markers
High heterozygosity values are important in selecting
STR markers for human identification purposes [41]. In
general, markers with high heterozygosity values give a
greater chance of discriminating between any two indivi-
duals. Observed heterozygosity values greater than 70%
were used in the selection process for STR markers for
human identification applications [19]. Observed hetero-
zygosity values were measured for each of the markers
Figure 2 Electropherogram representing a mixture of Vero and HeLa cell DNA (10:1 ratio, respectively). Genetic profiles were analysed
using bins and panels developed in GeneMapper ID-X. Relative fluorescent units (RFUs) are depicted on the y-axis and fragment length on the
x-axis in the electropherogram. Arrows depict HeLa alleles which may or may not appear in the bins and panels designated for Vero samples.
Vero alleles appear in the shaded bins and panels designated for each STR marker. The number(s) below each peak represent the number of
repeats at that locus. At the D4S2408, D5S4167, and D19S245 markers, HeLa DNA amplifies outside the observed vervet allele range and those
values are represented as fragment lengths (bp) instead of repeat numbers. HeLa cells do not amplify at the DYS389 locus because they are of
female origin. Human allele ranges that differ from vervet monkeys are illustrated in yellow boxes.
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mic DNA samples (Table 5). The two loci that resulted
in the highest observed heterozygosity values are
D19S245 (0.790) and D1S518 (0.710). The STR markers
with the lowest observed heterozygosity values (0.532)
were DYS389 and D4S2408. The D1S518 locus gave
comparable results to those published by Newman et al.
[30]. These researchers used a smaller sample size of
fifty-five monkeys, and found five alleles associated with
this locus with an observed heterozygosity value of 0.596.
The heterozygosity value for D1S518 calculated in this
study is higher (0.710) than the value calculated in the
Newman paper and is likely due to the number and type
of samples analyzed in each study. The probability of
identity (PI) was calculated for each marker (Table 5).
For example, the D8S1106 marker has a probability of 1
in 9 that any two vervet samples would match at this
marker. Since the eight markers are all located on sepa-
rate chromosomes, we can multiply the probability of
identity for each marker to determine a random match.
The probability of a random match using eight STR mar-
kers between any two vervet samples is 1 in 1.9 million.
Species specificity of the assay and profile stability
To determine the specificity of the selected STR mar-
kers, genomic DNA from pig, mouse, hamster, rat, ger-
bil, baboon, rhesus, and cynomolgus monkey were
tested using the vervet multiplex assay. DNA samples
with concentrations ranging from 2 ng to 100 ng were
added to individual reactions and samples were ampli-
fied according to the methods in the PCR amplification
section. All eight non-vervet DNA samples resulted in
incomplete or irregular profiles in the limited number of
samples tested based on the bins and panels developed
for the vervet monkey in GeneMapper ID-X (data not
shown). To further explore the genetic diversity between
these species would require screening of additional sam-
ples; however, this is beyond the scope of the study.
A multiplex assay that can detect contamination of
other cell lines within a mixed sample would be useful.
Contamination of Vero cells with another vervet cell
line (CV-1) or a human cell line (HeLa) was analyzed
using simulated mixture samples. Mixture ratios ranging
from 1:1 to 10:1 consistently showed mixed profiles
using the multiplex assay. Even at the highest dilution
in Vero DNA (5.45 ng), low concentrations of HeLa and
CV-1 DNA (0.55 ng) were detected within a Vero pro-
file (See Figure 2). The inverse is also true. Samples con-
taining low levels of Vero DNA (0.55 ng) produced a
full Vero profile even with high levels of CV-1 DNA
present and resulted in a partial profile with high levels
of HeLa DNA. The partial profile consisted of six STR
markers, D8S1106, DYS389, D1S518, D17S1304,
D5S1467, and D19S245, and the remaining two loci,
D4S2408 and D6S1017, resulted in peaks that were
below the analytical threshold of 50 relative fluorescent
units (RFU).
Genetic stability of the eight STR markers was evalu-
ated over high cell passage number to ensure a stable
profile will be generated as the cell line ages. DNA
extracted from Vero cells harvested at passage numbers
7, 14, 22, 35, 43, 58, 63, and 69 were analyzed using the
multiplex assay. After samples were amplified and sepa-
rated based on fragment length, it was determined that
there was complete concordance in the Vero profile up
to 69 passages. These data suggest that the STR loci are
stable with low mutation rates in the Vero cell line.
Conclusions
A multiplex assay based on eight human STR markers
with observed heterozygosity values ranging from 0.532
to 0.790 was developed, and the probability of a random
match using these markers between any two vervet sam-
ples is approximately 1 in 1.9 million. There are several
advantages of using an STR assay to genotype vervet
cells and their derivatives including the ability to obtain
more information from a multiplex, the rapid detection
using PCR and capillary electrophoresis separation, and
the relative low cost of materials and reagents.
The markers described in this assay can be useful to
authenticate cell lines derived from individual vervet
monkeys; however, vervet cells derived from the same
individual will result in identical profiles. Additional spe-
cific assays are required to distinguish between cell lines
derived from the same origin. For example, COS-7 and
CV-1 cells result in the same genetic STR profile, so a
test for SV40 T antigen could be used to differentiate
COS-7 cells from CV-1 cells [39].
Genetic stability of the eight loci in this assay was
shown to be consistent at high passage in the Vero cell
line over a period of six months. This supports the find-
ings of Chiong et al.w h e r et h e yc o n c l u d e dS T R
Table 5 Observed heterozygosity and probability of
identity values calculated for STR markers in the vervet
multiplex samples
STR Marker Number of Alleles H
(obs)
PI
(obs)
D8S1106 5 0.645 0.111
DYS389 4 0.532 0.226
D1S518 5 0.710 0.143
D6S1017 6 0.629 0.222
D17S1304 5 0.677 0.110
D4S2408 6 0.532 0.282
D5S1467 4 0.581 0.264
D19S245 7 0.790 0.082
Heterozygosity (H) and probability of identity (PI) values were calculated for
each STR marker using data from sixty-two vervet monkeys.
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change with passage number [42]. Parson et al.
described genetic stability in some human leukemia cell
lines and instability in others after passaging cells for
one year and analyzing the DNA fingerprints using STR
markers [43]. High cell passage number has been shown
to increase the risk of alterations in DNA fingerprinting
and best practices suggest cell identification at low pas-
sage numbers [44].
In addition to authenticating vervet cell lines, this
assay may be a useful indicator for human cell line con-
tamination since the assay is based on human STR mar-
kers. Human DNA amplifies at each marker; however,
the fragment sizes are outside the observed vervet allele
range at the following loci: D4S2408, D5S1467,
D19S245, and DYS389. Human cell line contamination
can be confirmed using validated STR markers [17]. The
vervet multiplex assay was unable to generate complete
profiles in the observed vervet allele range for more dis-
tantly related species, and we are currently developing
additional markers to target several of these in an all-
inclusive multiplex assay.
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